Clinical Trials News

 Business Wire Health: Clinical Trials News

Xeris Pharmaceuticals Doses First Patient in Phase 2 Trial Evaluating Its Developmental Ready-to-use Glucagon in Patients at Risk From Hypoglycemia Following Bariatric Surgery

CHICAGO--(BUSINESS WIRE)--Xeris has dosed the first subject in a Phase 2 trial with its developmental ready-to-use glucagon in patients with PBH.

Business Wire Health: Clinical Trials News

15:00

Mark above section as read

 PBR - Clinical Trials News

Acceleron completes target enrollment in phase 2 trial of Sotatercept in PAH

The Company now expects to report top-line results during the first quarter of 2020. “We’re thrilled with PULSAR’s rapid enrollment over the past 12 months, which underscores the The post Acceleron completes target enrollment in phase 2 trial of Sotatercept in PAH appeared first on Pharmaceutical Business review.

PBR - Clinical Trials News

14:59

Mark above section as read

 SAGE Publications: Clinical Trials: Table of Contents

Proceedings of the University of Pennsylvania 11th annual conference on statistical issues in clinical trials: Estimands, missing data and sensitivity analysis

Clinical Trials, Ahead of Print.

SAGE Publications: Clinical Trials: Table of Contents

12:33

University of Pennsylvania 11th annual conference on statistical issues in clinical trials: Estimands, missing data and sensitivity analysis (afternoon panel session)

Clinical Trials, Ahead of Print.

SAGE Publications: Clinical Trials: Table of Contents

12:32